Arrowhead Pharmaceuticals (HDP1.F) Q2 2024 Earnings

9MayConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-1.75
-1.31
-0.87
-0.44

Details

Expected EPS
-0.43754475280000005
Actual EPS
-0.945744
Surprise EPS
-0.51
Surprise Percent
+116.15%

Description

Arrowhead Pharmaceuticals (HDP1.F) has reported earnings of -0.945744 per share for Q2 2024.

0 Comments

Share your thoughts